gptkbp:instanceOf
|
public-private partnership
|
gptkbp:abbreviation
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator
|
gptkbp:aimsTo
|
accelerate antibacterial innovation
|
gptkbp:collaboratesWith
|
gptkb:Boston_University
gptkb:Biomedical_Advanced_Research_and_Development_Authority
gptkb:National_Institute_of_Allergy_and_Infectious_Diseases
|
gptkbp:focusesOn
|
gptkb:antibiotic
antibiotic resistance
antibacterial research
|
gptkbp:foundedIn
|
2016
|
gptkbp:fundedBy
|
gptkb:UK_Government
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:U.S._Department_of_Health_and_Human_Services
gptkb:Wellcome_Trust
gptkb:German_Federal_Ministry_of_Education_and_Research
|
gptkbp:headquartersLocation
|
gptkb:Boston_University
|
https://www.w3.org/2000/01/rdf-schema#label
|
CARB-X
|
gptkbp:operatesIn
|
global
|
gptkbp:supports
|
therapeutics development
diagnostics development
early-stage antibacterial R&D
preventive products development
|
gptkbp:website
|
https://carb-x.org/
|
gptkbp:bfsParent
|
gptkb:Bug_Works
gptkb:Bugworks
|
gptkbp:bfsLayer
|
7
|